Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data SciSparc Ltd. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2015
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Revenue
1.35
2.88
1.31
Cost of revenue
0.32
0.68
0.8
Gross profit
1.03
2.2
0.51
Research and development
-0.24
0.74
1.94
2.71
1.64
0.65
1.99
2.8
1.64
1.71
Selling, general and administrative
2.47
1.9
3.78
5.97
5.03
General and administrative
4.37
2.47
1.9
Operating income
2.56
-2
-5.75
-7.24
-4.11
-3.29
-5.77
-8.29
-6.82
-7.32
Interest expense
-0.01
0.01
0.49
0.12
0.68
0.87
0.02
2.01
1.06
0.35
Interest income
-0.01
0
0
0.83
0.31
0.63
7.83
2.22
0.61
Pre-tax income
2.62
-2.01
-6.24
-9.01
-3.54
-5.79
-2.58
-5.86
-7.49
Income tax
-0.06
0.01
0.02
-0.01
Income from continuing operations
-6.24
-6.53
-4.48
-3.54
-5.79
Net income to minority interests
0.08
0.01
0.43
-0.11
0.05
-0.76
-1.19
Net income
2.54
-2.01
-6.24
-8.95
-4.69
-3.54
-5.79
-2.59
-5.12
-6.28
EPS, basic
2.20
1.00
1.00
1.20
0.64
0.10
73.58
14.82
14.43
1.28
EPS, diluted
2.20
1.00
1.00
1.20
0.64
0.11
73.58
14.82
14.43
1.28
Balance sheet
FY2015
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Cash and equivalents
1.57
0.68
9.2
1.49
0.87
7.78
6.88
3.57
2.08
1.54
Inventory
0.67
0.74
0.11
Total current assets
0.8
9.5
2.43
0.96
2.55
9.82
4.51
6.45
7.5
Property, plant and equipment
0.01
0.05
2.11
0.18
0.01
0.09
0.06
0.11
0.06
Intangible assets
4.72
3.19
1.48
Total assets
1.25
9.57
0.28
1.15
2.56
9.92
10.6
11.2
10.3
Accounts payable
0.08
0.16
0.84
0.11
0.03
0.15
0.19
0.19
0.21
Total current liabilities
0.67
1.18
4.48
1.05
1.13
1.76
4.16
1.57
1.4
Lease liabilities
0.09
0.02
0.02
0.01
Total liabilities
0.67
1.18
4.48
1.14
1.13
1.78
4.16
1.6
1.41
Paid-in capital
26.6
36.6
38.1
39.3
58.6
64.5
70.9
Retained earnings
-32.1
-38.4
-46.9
-51.7
-55.2
-61
-63.6
-68.7
-75
Shareholders' equity
8.39
0.19
0.01
6.45
7.61
8.15
Minority interests
-0.11
1.97
0.79
Total equity
1.16
0.57
8.39
0.08
0.01
1.43
8.14
6.45
9.59
8.94
Total liabilities and equity
1.25
9.57
4.56
1.15
2.56
9.92
10.6
11.2
10.3
Cash flow statement
FY2015
FY2017
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
Net income
2.62
-2.01
-6.24
-8.95
-4.69
-3.54
-5.79
-2.59
-5.88
-7.47
Cash from operations
-1.4
-1.47
-4.58
-7.13
-4.7
-4.31
-5.06
-7.92
-5.89
-5.1
Capital expenditures
-0
-0
-0.04
-0.02
-0
-0.04
-0.01
Cash from investing
-0
-0.01
-0.05
-2.09
1.27
0.02
-0.07
-7.08
-4.09
-1.63
Debt issued
1.46
13.2
2.22
2.65
7.7
9.01
Stock issued
9.01
5.55
6.26
Cash from financing
2.75
0.57
13.2
1.54
2.8
5.36
10.1
11.7
8.48
6.19
Exchange rate effect
0.08
-0.01
-0.53
0.3
0.01
Net change in cash
1.42
-0.9
8.52
-7.71
-0.62
1.08
4.93
-3.3
-1.5
-0.54
Free cash flow
-1.41
-1.48
-4.62
-7.15
-4.7
-5.1
-7.93
Key metrics
Worked out from the statements above. Latest values use fiscal 2024. Valuation uses the share price of $0.40 on November 11, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
38.7%
Gross profit / revenue.
Operating margin
-560.2%
Operating income / revenue.
Pre-tax margin
-573.2%
Pre-tax income / revenue.
Net margin
-481.2%
Net income / revenue.
Operating cash flow margin
-390.8%
Cash from operations / revenue.
Return on equity (ROE)
-79.7%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
-58.4%
Net income / average total assets.
Return on invested capital (ROIC)
-95.1%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
130.7%
Research and development expense / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-54.6%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
-77.0%
Gross profit vs the same period a year earlier. Only from a positive base.
EPS growth, 1y
-91.1%
EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y
-74.1%
Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y
14.9%
Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y
7.1%
Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 5y
257.3%
Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y
-7.5%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
1.4%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
55.1%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
5.36x
Current assets / current liabilities.
Quick ratio
1.10x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
1.10x
(Cash + short-term investments) / current liabilities.
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
EPS, basic
$1.28
Net income per basic share, as reported (split-adjusted).
Valuation
Metric
Value
How it is calculated
Market cap
$229.9K
Share price x shares outstanding.
Enterprise value
-$1.3M
Market cap + total debt - cash - short-term investments.
P/S
0.18x
Market cap / revenue.
P/B
0.03x
Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book
0.03x
Market cap / tangible book value, when positive.
Earnings yield
-2,734.0%
Net income / market cap (the inverse of P/E).
What was SciSparc Ltd.'s revenue in fiscal 2024?
SciSparc Ltd. reported revenue of $1.3M for fiscal 2024, 54.6% lower than the year before.
Was SciSparc Ltd. profitable in fiscal 2024?
No. It reported a net loss of $6.3M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.